Doctor Mika Lehto
Helsinki University Hospital, Helsinki (Finland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study
Event: ESC Congress 2023
Topic: Oral Anticoagulation
Session: Atrial fibrillation and high-rate episodes: stroke prediction and prevention
How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.
Event: EHRA 2023
Topic: Oral Anticoagulation
Session: Atrial Fibrillation - Round 1 - Stroke - OAC
Prevalence of atrial fibrillation - a comprehensive nationwide analysis in Finland
Event: ESC Congress 2022
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Insights from atrial fibrillation registries and observational studies
Incidence of atrial fibrillation. A comprehensive nationwide analysis in Finland.
Event: ESC Congress 2021 - The Digital Experience
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Congress committee e-posters choice in arrhythmias and device therapy
All you want to know about the arrhythmia: A comprehensive, nationwide registry study of atrial fibrillation in Finland
Event: EHRA 2021
Topic: Public Health and Health Economics, Other
Session: ePoster session
